Momenta Pharmaceuticals (NASDAQ:MNTA) reported 12/31/2018 earnings this Morning, coming in at ($0.08) per share, beating Wall Street’s estimates of ($0.46) per Share. Revenue for the quarter came in at $42.80 million beating analyst estimates of $17.11 million

Recent Trading for Momenta Pharmaceuticals (NASDAQ:MNTA)
Shares of Momenta Pharmaceuticals closed the previous trading session at with 14.35 shares trading hands.